Autophagy positively regulates Wnt signaling in mice with diabetic retinopathy

Area of Science:

• Ophthalmology
• Molecular Biology
• Endocrinology

Background:

• Diabetic retinopathy (DR) is a diabetes complication involving microvascular damage.
• Aberrant Wnt signaling activation is implicated in DR pathogenesis.
• The precise mechanisms linking Wnt signaling and DR remain unclear.

Purpose of the Study:

• To investigate the regulatory role of autophagy in Wnt signaling within the context of diabetic retinopathy.
• To explore the potential of modulating autophagy as a therapeutic strategy for DR.

Main Methods:

• Utilized db/db mice models to study retinal changes in diabetic retinopathy.
• Administered autophagy modulators (3-methyladenin, rapamycin, chloroquine) to mice and cultured Müller cells.
• Assessed the expression of autophagy proteins (LC3, beclin-1, P62) and Wnt signaling activity.

Main Results:

• Wnt signaling was activated in diabetic retinas, correlating with increased autophagy markers (LC3, beclin-1) and decreased P62.
• Inhibition of autophagy reduced Wnt signaling in diabetic retinas.
• Autophagy induction (rapamycin) upregulated Wnt signaling in normal retinas and Müller cells, while inhibition (chloroquine) downregulated it.

Conclusions:

• Autophagy appears to positively regulate Wnt signaling in the retina.
• This suggests a potential mechanism for Wnt signaling upregulation in diabetic retinopathy.
• Modulating autophagy presents a potential novel therapeutic target for treating diabetic retinopathy.